The MeDALL Project is funded by the 7th Framework Programme (FP7) as a consortium of 23 partners, of both public and private institutions, which seeks to gather leading experts in clinical allergy (Allergology, asthma, atopic dermatitis, food allergy and pediatrics), epidemiology, genetics, immunology molecular biology, allergen biochemistry and bioinformatics. Together the stakeholders collaborate to investigate the causes of allergy in order to improve the health of European citizens with results which can improve the quality of life among allergy patients across Europe. The project specifically targets the improvement of early diagnosis, primary and secondary prevention strategies and the development of cost-effective treatments for allergic disorders.
Additional information is available for download below or by visiting the MeDALL website.
You must be logged in to post a comment.